- Home
- / Lipella Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lipella Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.4
2024-10-29
Market Capitalization
$4 M
2024-10-29
Revenue
$536.4 K
FY, 2024
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|
| Revenue | 184.2K | 449.6K | 536.4K |
| General and administrative expense | 226.2K | 2.2M | 2.0M |
| Operating expense total | 2.8M | 5.2M | 5.6M |
| EBIT | (2.6M) | (4.7M) | (5.1M) |
| EBIT margin, % | -1406.3% | -1055.6% | -947.2% |
| Interest income | 1.7K | 137.8K | 64.3K |
| Interest expense | 9.6K | 10.8K | |
| Pre tax profit | (2.6M) | (4.6M) | (5.0M) |
| Net Income | (2.6M) | (4.6M) | (5.0M) |
| EPS | (0.6) | (0.8) | (4.8) |